Literature DB >> 31940114

Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.

Alessandro Maria Ferrazza1, Antonietta Gigante2, Maria Ludovica Gasperini2, Rosa Maria Ammendola1, Gregorino Paone3, Iacopo Carbone1, Edoardo Rosato4.   

Abstract

Interstitial lung disease (ILD) remains a major cause of morbidity and mortality in systemic sclerosis (SSc). Study aim is to characterize and quantify SSc-ILD by using Computer-Aided Lung Informatics for Pathology Evaluation and Rating (CALIPER). Secondly, our objective is to evaluate which radiological pattern is predictive of lung function decline at 12 months follow-up. In the prospective study (IRB 5435), 66 SSc patients underwent high-resolution computerized tomography (HRCT) at baseline. HRCT was performed according to standard protocol using a CT 64GE light speed VCT power scanner. CALIPER classified lung parenchyma on volume units. Every volume unit was classified into radiological parenchymal patterns (honeycombing, reticular and ground glass). Pulmonary function tests (PFTs) were performed at baseline and after 12 months of follow-up. Cigarette smoking and other lung diseases unrelated to SSc are exclusion criteria. CALIPER analysis showed normal lung parenchyma 87.4 ± 9.8%, ground glass 2.8 ± 5.3%, reticular 4 ± 5.7%, and honeycombing 1 ± 1%. In multiple regression analysis, FEV1 (p < 0.0001), FVC (p = 0.001), and DLCO (p < 0.0001) measurements at baseline showed a negative correlation with the reticular pattern percentage. At follow-up, DLCO reduction showed a positive correlation (p < 0.001) with the percentage of ground glass pattern (r = 0.33, beta coefficient = 0.51). In the ROC curve analysis, ground glass score is a good predictor (0.75, p = 0.009; 95% CI 0.59-0.91) of DLCO worsening, defined as a decrease of more than 10% of DLCO. Using a cutoff ≥ 4.5 for ground glass score, the RR for DLCO worsening is 6.8 (p < 0.01; 95% CI 1.6-29.2). The results of this study show that CALIPER is useful not only for quantifying lung damage but also for assessing worsening PFTs, but larger studies are needed to confirm these preliminary data.Key Points• At baseline reticular pattern showed negative correlation with PFTs• At follow-up ground glass pattern predicts worsening of DLCO• CALIPER is a useful to quantify lung damage.

Entities:  

Keywords:  CALIPER; HRCT; Interstitial lung disease; Pulmonary function tests; Systemic sclerosis

Year:  2020        PMID: 31940114     DOI: 10.1007/s10067-020-04938-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis.

Authors:  Alarico Ariani; Mario Silva; Valeria Seletti; Elena Bravi; Marta Saracco; Simone Parisi; Fabio De Gennaro; Luca Idolazzi; Paola Caramaschi; Camilla Benini; Flavio Cesare Bodini; Carlo Alberto Scirè; Greta Carrara; Federica Lumetti; Veronica Alfieri; Elisa Bonati; Gianluca Lucchini; Marina Aiello; Daniele Santilli; Flavio Mozzani; Davide Imberti; Emanuele Michieletti; Eugenio Arrigoni; Giovanni Delsante; Raffaele Pellerito; Enrico Fusaro; Alfredo Chetta; Nicola Sverzellati
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

2.  Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Maria Kokosi; Arjun Nair; Ronald Karwoski; Simon L F Walsh; Athol U Wells; David M Hansell
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

3.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

Review 4.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

5.  Quantitative computed tomography imaging of interstitial lung diseases.

Authors:  Brian J Bartholmai; Sushravya Raghunath; Ronald A Karwoski; Teng Moua; Srinivasan Rajagopalan; Fabien Maldonado; Paul A Decker; Richard A Robb
Journal:  J Thorac Imaging       Date:  2013-09       Impact factor: 3.000

6.  Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Maria Kokosi; Arjun Nair; Ronald Karwoski; Sushravya M Raghunath; Simon L F Walsh; Athol U Wells; David M Hansell
Journal:  J Thorac Imaging       Date:  2016-09       Impact factor: 3.000

7.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

8.  Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.

Authors:  Misbah Baqir; Ashima Makol; Thomas G Osborn; Brian J Bartholmai; Jay H Ryu
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

9.  Segmentation of Pulmonary Vascular Trees from Thoracic 3D CT Images.

Authors:  Hidenori Shikata; Geoffrey McLennan; Eric A Hoffman; Milan Sonka
Journal:  Int J Biomed Imaging       Date:  2009-12-14

10.  Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.

Authors:  Sabine Adler; Dörte Huscher; Elise Siegert; Yannick Allanore; László Czirják; Francesco DelGaldo; Christopher P Denton; Oliver Distler; Marc Frerix; Marco Matucci-Cerinic; Ulf Mueller-Ladner; Ingo-Helmut Tarner; Gabriele Valentini; Ulrich A Walker; Peter M Villiger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

View more
  3 in total

1.  The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis.

Authors:  Tao Yang; Chihua Chen; Zhongyuanlong Chen
Journal:  BMC Pulm Med       Date:  2021-01-20       Impact factor: 3.317

Review 2.  Computer-Aided quantitative analysis in interstitial lung diseases - A pictorial review using CALIPER.

Authors:  Bhavin G Jankharia; Bhoomi A Angirish
Journal:  Lung India       Date:  2021 Mar-Apr

Review 3.  Towards Treatable Traits for Pulmonary Fibrosis.

Authors:  Thijs W Hoffman; Jan C Grutters
Journal:  J Pers Med       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.